Latest news for flexisyn online review

Average Rating: 4.7 out of 5 based on 201 user reviews.

The terminology used by analysts is anything but uniform, many of the analysts use the conventional terms "buy", "hold" and "sell" for making their recommendations, which makes sense, as that's what investors do, buy, hold and sell for their . However, there are a plethora of terms used by analysts having unclear meanings, for example a popular recommendation is "accumulate". A lot of the stuff I purchase "accumulates", and a lot of it ends up in the garage or the basement, so how does a person go about "accumulating" a stock, buy a little here, and a little there? Another term the analysts like to use is "strong buy". So how does a person execute a "strong buy"? There must be a special button on the broker's web site for executing a "strong buy", but I've never seen it. "Market outperform", "market perform", and "market underperform" are some other analyst terminology. Does this mean we're supposed to watch it "perform", are we supposed to clap, exactly what are we supposed to do with this information? A term I really like is "neutral", when an analyst says he's neutral, what does that mean? When my car's in neutral it doesn't go anywhere, I want to own stocks that are going to go up, not be parked in neutral. And then there are the eating disorder recommendations, "overweight", "equal-weight" and "underweight". Does overweight mean to buy the stock flexisyn online review, or flexisyn online review does the term imply we should gorge on the stock? There are many other terms which are equally confusing: "trading buy", "trading sell", "in-line", "positive", "negative", "under review", "peer perform", "long-term buy", "speculative investment", and "sector perform". What should we do with all of this information? We've analyzed the record of the analysts going back to February 1998 for all current stocks listed on the Nasdaq, NYSE and American stock exchanges. Stocks for companies going belly up or delisted are not included as are companies that have been acquired by or merged with other companies, and analysts [flexisyn online review] without a recommendation issued in 2006 were also not considered. For this analysis, we assumed "market outperform" means a buy, "market underperform" means the stock is to be sold, etc. Another issue we must take into consideration is that analysts sometimes recommend a stock for a buy, and then cease to cover the stock, but never issue a sell recommendation, for this case we just assumed we're supposed to continue holding the stock. This behavior seems a little inconsiderate, as the analyst convinces a person to purchase a position, then just leaves them there holding the stock without any recommendation as to what they are supposed to do with it. Flexisyn online review the results of our analysis are show below:

analyst start date end date best pick best pick % ret worst pick worst pick % ret # co's cvrd % right avg % ret s&p 500 % ret % ret over s&p 500
ag edwards mar98 may06 pmk 1696% anlt -100% 694 68% 51% 22% 29%
adam harkness mar98 jan06 4825% emrg -100% 331 45% 32% 17% 15%
am tech/jsa research may05 may06 102% -34% 48 56% 5% 7% -2%
avondale partners aug03 may06 394% trmm -68% 81 65% 27% 31% -4%
b. Riley Apr02 Apr06 1155% -64% 51 59% 52% 19% 33%
BB&T Capital Mkts Mar00 Jun06 799% VERT -100% 269 72% 55% -14% 69%
Banc of America Sec May99 May06 2281% -100% 993 61% 39% -1% 40%
Barrington Research Jul99 May06 362% PRGX -94% 90 67% 31% -5% 36%
Bear Stearns Mar98 Jun06 2365% GOAM -100% 751 61% 57% 17% 40%
Bernstein Aug01 Apr06 363% -57% 96 74% 44% 5% 39%
Brean Murray Aug98 Jun06 410% AKSY -87% 161 48% 13% 17% -4%
CE Unterberg Towbin Oct98 May06 738% GOAM -100% 247 38% 4% 23% -19%
CIBC World Market May99 Jun06 1516% -100% 806 56% 43% 0% 43%
CL King Dec04 Jun06 171% -67% 46 65% 15% 7% 8%
Credit Suisse Feb98 May06 6144% VERT -100% 1238 64% 64% 23% 41%
Calyon Securities Mar05 May06 114% -32% 58 67% 12% 9% 3%
Caris and Co. Jun03 Jun06 420% GENR -81% 160 50% 8% 27% -19%
Citigroup Aug05 May06 216% -56% 196 62% 8% 3% 5%
Cowen and Co Mar98 Jun06 534% ARDM -98% 32 50% 40% 23% 17%
DA Davidson Aug98 Jun06 613% -89% 144 72% 44% 20% 24%
Deutsche Securities Jul98 Jun06 660% -83% 605 68% 37% 10% 27%
Dougherty and Co. Feb01 May06 582% ISIG -84% 79 58% 35% 2% 33%
FTN Midwest Oct03 Jun06 114% -60% 76 66% 11% 23% -12%
Ferris Baker Nov98 May06 684% VYYO -89% 185 67% 36% 13% 23%
First Albany Feb02 Jun06 918% ATAR -85% 341 56% 30% 16% 14%
First Analysis Sec. Sep99 Jun06 1716% -99% 61 49% 53% -2% 55%
Friedman Billings Apr98 May06 7053% -98% 519 65% 67% 16% 51%
Global Crown Capital Aug05 Jun06 44% -50% 20 55% 4% 5% -1%
Goldman Sachs Feb98 Jun06 1306% -100% 886 66% 56% 25% 31%
HSBC Securities Apr98 May06 264% FTE -69% 39 62% 32% 18% 14%
Harris Nesbitt Jul03 Jun06 349% PARS -87% 138 62% 12% 30% -18%
Hibernia Southcoast Capital Oct04 Apr06 144% -72% 61 75% 27% 16% 11%
Hilliard Lyons Apr98 May06 24% LANV -16% 24 67% 4% 14% -10%
Investec Jun02 Jan06 1454% -85% 38 71% 112% 25% 87%
J. P. Morgan Mar98 Jun06 3555% ICGE -100% 1063 67% 47% 20% 27%
JMP Securities Jul02 Jun06 351% GNTA -87% 260 59% 22% 36% -14%
Janco Partners Oct04 Jun06 141% COOL -85% 30 47% 3% 13% -10%
Janney Montgomery Feb99 May06 931% VERT -100% 204 66% 48% 5% 43%
Jefferies Apr98 Jun06 1838% -100% 650 65% 51% 17% 34%
Kaufman Bros. Feb99 Jun06 6444% FTGX -100% 162 43% 54% 1% 53%
Keefe Bruyette Mar98 Jun06 1495% PXT -84% 139 79% 44% 21% 23%
KeyBanc Capital Mkts/ McDonald Apr04 May06 603% JAS -56% 213 71% 25% 13% 12%
Ladenburg Thalman Oct98 May06 1335% VLTS -97% 97 46% 36% 21% 15%
Lazard Captial Nov05 May06 43% WRNC -31% 22 45% -3% 6% -9%
Leerink Swann Jul03 May06 139% DYAX -72% 51 43% 3% 30% -27%
Lehman Brothers Feb98 May06 2281% ICGE -100% 1153 65% 49% 23% 26%
Longbow Aug04 May06 402% -56% 41 78% 44% 19% 25%
Matrix Research Jan06 Jun06 371% -55% 129 44% 1% 1% 0%
Merrill Lynch Feb98 Apr06 2302% VERT -100% 1187 65% 70% 25% 45%
Merriman Curhan Ford Oct03 Jun06 462% SQNM -83% 166 46% 9% 23% -14%
Miller Johnson Jan04 Jun06 190% CRAY -74% 32 50% 22% 12% 10%
Moors and Cabot Sep03 Feb06 86% ASYT -77% 65 60% 6% 25% -19%
Morgan Joseph Jan05 Jun06 594% XMSR -58% 49 55% 25% 8% 17%
Morgan Keegan May98 May06 1532% PRW -95% 204 66% 73% 17% 56%
Morgan Stanley Mar98 Jun06 2281% GOAM -100% 1090 65% 49% 23% 26%
Needham Nov98 May06 586% ITWO -99% 420 49% 19% 13% 6%
Nollenberger Capital Oct05 Apr06 56% -28% 24 54% 4% 9% -5%
Oppenheimer Sep03 May06 384% VION -65% 212 56% 9% 26% -17%
Pacific Crest Mar99 May06 588% VERT -100% 118 46% 21% 0% 21%
Pacific Growth Equities Dec99 Jun06 1030% ITWO -99% 235 50% 26% -10% 36%
Piper Jaffray Feb98 May06 6132% PRGX -98% 412 58% 42% 24% 18%
Prudential Feb98 Jun06 927% -99% 762 65% 58% 23% 35%
Punk Ziegel Jul98 May06 696% CTIC -91% 62 50% 35% 14% 21%
RBC Capital Mkts Nov01 Jun06 851% UPCS -93% 438 70% 39% 15% 24%
Robert W. Baird Dec99 May06 636% VERT -100% 484 65% 31% -10% 41%
Rodman and Renshaw Sep02 May06 307% ALT -95% 82 41% 0% 58% -58%
Roth Capital Mar00 Jun06 1489% MBAY -99% 192 57% 47% -12% 59%
Ryan Beck and Co Oct02 May06 480% ALT -96% 136 69% 30% 66% -36%
Sanders Morris Harris Mar03 May06 550% CPWM -63% 87 69% 50% 49% 1%
Sandler O'Neill Nov04 May06 172% NPTE -24% 82 83% 16% 9% 7%
Soleil Dec05 May06 30% WIND -38% 45 49% -2% 1% -3%
Southwest Sec Jan99 Jan06 1146% ARTG -95% 120 53% 49% 15% 34%
Stanford Nov04 Jun06 153% SGTL -81% 119 67% 13% 10% 3%
Stephens Inc. Mar98 May06 1420% -99% 212 66% 66% 20% 46%
Stifel Nicolaus Mar00 May06 966% ELOY -92% 183 66% 41% -14% 55%
Susquehanna Financial Nov04 May06 117% INCY -39% 104 48% 6% 10% -4%
ThinkEquity Apr03 May06 365% BPUR -95% 106 53% 14% 45% -31%
Thomas Weisel Jun99 Jun06 668% -100% 492 51% 9% -4% 13%
UBS Jun03 Jun06 702% DCN -96% 537 66% 23% 29% -6%
WR Hambrecht Feb00 May06 468% -100% 276 50% 20% -9% 29%
Wachovia Apr00 May06 1016% VITR -96% 501 65% 31% -12% 43%
Wedbush Morgan Sep99 May06 466% DLK -99% 196 56% 20% -4% 24%
William Blair Jul99 May06 590% -96% 234 56% 20% -3% 23%
According to this analysis (only currently available stocks on Nasdaq, NYSE and American), 70% of the analysts outperformed the S&P500 Index () over the time period of coverage, the recommendation with the largest return was Friedman Billings recommendation of NewMarket Corp ( <> 7053%), the analyst with the best average return (112%) and the best performance compared to the S&P500 (excess return 87%) was Investec, and the analyst with the best success rate was Sandler O'Neil (83%). Lazard Capital generated the worst average return (-3%) (Note: Lazard Capital's time of coverage is very short), Rodman and Renshaw turned in the worst performance compared to the S&P500 Index (-58%) and CE Unterberg Towbin exhibited the worst success rate (38%). Interestingly, almost all of the analysts recommended "dogs with fleas", the average of the worst pick returns was -82% and the average analyst success rate was 60%, so unless the analyst has a few home runs to make up for the "dogs with fleas", their results generally aren't very good. At PowerOptions, our patented search tools were developed to aid customers in generating consistent income with smaller wins, but also with fewer and smaller "dogs with fleas". [tags]stock market research, personal stock portfolio, stock research[/tags]


?? 2008-2016 Legit Express Chemist.